What's new? Log in Free sign up

Nemaura Medical (NMRD) News and press releases

Company Profile

News

From Benzinga Pro

EF Hutton Reiterates Buy on Nemaura Medical, Maintains $6 Price Target

News, Price Target, Reiteration, Analyst Ratings

EF Hutton analyst Constantine Davides reiterates Nemaura Medical (NASDAQ:NMRD) with a Buy and maintains $6 price target.

Stocks That Hit 52-Week Lows On Monday

On Monday, 198 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Thursday

Thursday's session saw 337 companies set new 52-week lows.

EF Hutton Maintains Buy on Nemaura Medical, Maintains $6 Price Target

News, Price Target, Analyst Ratings

EF Hutton analyst Constantine Davides maintains Nemaura Medical (NASDAQ:NMRD) with a Buy and maintains $6 price target.

HC Wainwright & Co. Maintains Buy on Nemaura Medical, Lowers Price Target to $7

News, Price Target, Analyst Ratings

HC Wainwright & Co. analyst Yi Chen maintains Nemaura Medical (NASDAQ:NMRD) with a Buy and lowers the price target from $8 to $7.

Nemaura Medical Q3 EPS $(0.07) Beats $(0.18) Estimate, Sales $3.02K Miss $170.00K Estimate

Nemaura Medical (NASDAQ:NMRD) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.18) by 61.11 percent. This is a 53.33 percent increase over losses of $(0.15) per share from

12 Health Care Stocks Moving In Friday's After-Market Session

Dow Gains Over 100 Points; Eastern Bankshares Shares Drop After Q4 Results

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.41% to 34,088.68 while the NASDAQ rose 1.27% to 11,659.16. The S&P 500 also rose, gaining, 0.57% to 4,083.57.

Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers FOXO Technologies Inc. (NYSE: FOXO) shares jumped 109% to $1.07. Akanda Corp. (NASDAQ: AKAN) rose 59% to $0.4459 after jumping 47% on Thursday.

12 Health Care Stocks Moving In Friday's Intraday Session

Nasdaq Jumps 100 Points; Crude Oil Down 1%

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow traded up 0.29% to 34,047.95 while the NASDAQ rose 0.88% to 11,613.37. The S&P 500 also rose, gaining, 0.41% to 4,077.05.

Why Nemaura Medical Stock Is Getting Hammered

News, Penny Stocks, Offerings

Nemaura Medical Inc (NASDAQ: NMRD) shares are trading lower by 38.8% to $1.75 Friday morning after the company announced pricing of a roughly $8.4 million registered direct offering and concurrent private placement.

US Stocks Higher; Dow Rises 150 Points

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded higher this morning, with the Dow Jones gaining over 50 points on Friday. Following the market opening Friday, the Dow traded up 0.47% to 34,107.87 while the NASDAQ rose 0.55% to 11,575.86. The S&P 500 also rose, gaining, 0.43% to 4,077.76.

Nemaura Medical Announces Pricing Of ~$8.4M Registered Direct Offering And Concurrent Private Placement

News, Offerings

Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized

Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $2.90. MicroAlgo recently entered into securities purchase agreement for up to $3.2 million.

12 Health Care Stocks Moving In Thursday's Intraday Session

Nasdaq Surges 100 Points; Tesla Beats Q4 Views

Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 33,824.53 while the NASDAQ rose 1.05% to 11,432.45. The S&P 500 also rose, gaining, 0.54% to 4,037.88.

Nemaura Medical Receives First Purchase Order From U.S. Health Provider HealthFleet; The Purchase Order Consists Of 75,000 ProBEAT Glucose Sensors Over An Initial Five Month Period And Is Valued At $500,000 In Revenue

News, Contracts

Nemaura to integrate its proBEATTM glucose sensors with HealthFleet's proven RestoreHealth wellness program targeted at U.S. Nemaura Medical, Inc. (NASDAQ:NMRD)("Nemaura" or the

Nemaura Medical Receives First Purchase Order From U.S. Health Provider HealthFleet

News, Contracts

Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized

Nemaura Medical's Program Shows Weight Loss In 100% Of Participants

News, Penny Stocks, Health Care, Movers, General

Press releases

From Benzinga Pro

Nemaura Medical to Participate in Fireside Chat Hosted by EF Hutton

LOUGHBOROUGH, March 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable sensors

Nemaura Medical Announces Receipt of Notice from Nasdaq

LOUGHBOROUGH, March 09, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD)("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable sensors and

Nemaura Medical Reports Fiscal Third Quarter 2023 Results and Provides Business Update

Loughborough, England, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable

Nemaura Medical to Participate in Fireside Chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Virtual Conference

Loughborough, England, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting

Nemaura Medical Announces Closing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement

LOUGHBOROUGH, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable sensors and

Nemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement

LOUGHBOROUGH, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable sensors and

Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet

Nemaura to integrate its proBEATTM glucose sensors with HealthFleet's proven RestoreHealth wellness program targeted at U.S. Nemaura Medical, Inc. (NASDAQ:NMRD)("Nemaura" or the "Company"), a medical technology company

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.